# Pilot Study of Edaravone to Treat Acute Myocardial Infarction

> **NCT00265239** · PHASE4 · COMPLETED · sponsor: **Kumamoto University** · enrollment: 104 (actual)

## Conditions studied

- Myocardial Infarction
- Reperfusion Injury

## Interventions

- **DRUG:** edaravone

## Key facts

- **NCT ID:** NCT00265239
- **Lead sponsor:** Kumamoto University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2014-09-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00265239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00265239, "Pilot Study of Edaravone to Treat Acute Myocardial Infarction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00265239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*